SCHEMBL4605809

SCHEMBL4605809

O=C(Br)CF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13651733 1.00
SCHEMBL7345138 0.70
SCHEMBL423978 0.67
Fluoroacetate SCHEMBL5908770 0.67
Fluoroacetate SCHEMBL13651728 0.67
SCHEMBL689143 0.67
SCHEMBL34263 0.67
SCHEMBL689061 0.67
SCHEMBL92092 0.67
SCHEMBL88444 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5539083-A FROM HALOACETYL HALIDE OR SULFONYLACETYL HALIDE, PROTECTED ALKYLENEDIAMINE, AND A DERIVATIVE OF A NUCLEIC ACID BASE ISIS PHARMACEUTICALS, INC. (US) 1996-07-23 US claimed
CN-103724215-A Novel derivative of 2-amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol and application of novel derivative ZHENJIANG SHENGAN PHARMACEUTICAL CO LTD 2014-04-16 CN disclosed
EP-1010684-B1 PROCESS FOR PRODUCING 3,4-DIHYDROXY-3-CYCLOBUTENE-1,2-DIONE KYOWA YUKA KK (JP) 2008-07-16 EP disclosed
EP-1676827-A2 Method for manufacturing 3-alkoxy-2-halogenocyclobutanone derivatives Kyowa Yuka Co., Ltd. (JP) 2006-07-05 EP disclosed
US-6756199-B1 USED FOR THE SYNTHESIS OF BOTH PREDEFINED AND RANDOM SEQUENCE PEPTIDE NUCLEIC ACID OLIGOMERS ISIS PHARMACEUTICALS, INC. 2004-06-29 US disclosed
US-6331653-B1 Process for producing 3,4-dihydroxy-3-cyclobutene-1,2-dione KYOWA YUKA CO., LTD. (JP) 2001-12-18 US disclosed
US-6204326-B1 ADDING PEPTIDE NUCLEIC ACID UNITS TO AN AMINE TERMINATED PEPTIDE NUCLEIC ACID OLIGOMER ON A SOLID PHASE SYNTHETIC RESIN; BIOSYNTHESIS ISIS PHARMACEUTICALS, INC. 2001-03-20 US disclosed
EP-1010684-A1 PROCESS FOR PRODUCING 3,4-DIHYDROXY-3-CYCLOBUTENE-1,2-DIONE Kyowa Yuka Co., Ltd. (JP) 2000-06-21 EP disclosed
EP-0777678-B1 PNA COMBINATORIAL LIBRARIES AND IMPROVED METHODS OF SYNTHESIS ISIS PHARMACEUTICALS INC (US) 1999-10-13 EP disclosed
US-5864010-A ENZYME INHIBITOR; ANTIINFLAMMATORY AGENT ISIS PHARMACEUTICALS, INC. (US) 1999-01-26 US disclosed
US-5831014-A OLIGOMERS WITH PEPTIDE NUCLEIC ACID UNITS AND AMINO ACID UNITS ISIS PHARMACEUTICALS, INC. (US) 1998-11-03 US disclosed
EP-0777678-A4 1997-07-16 EP disclosed
EP-0777678-A1 PNA COMBINATORIAL LIBRARIES AND IMPROVED METHODS OF SYNTHESIS ISIS PHARMACEUTICALS, INC. (US) 1997-06-11 EP disclosed
US-5539083-A FROM HALOACETYL HALIDE OR SULFONYLACETYL HALIDE, PROTECTED ALKYLENEDIAMINE, AND A DERIVATIVE OF A NUCLEIC ACID BASE ISIS PHARMACEUTICALS, INC. (US) 1996-07-23 US disclosed
WO-1995023163-A1 PNA COMBINATORIAL LIBRARIES AND IMPROVED METHODS OF SYNTHESIS ISIS PHARMACEUTICALS, INC. (US) 1995-08-31 WO disclosed
US-4402734-A N-(HALOALKYL)-N-(CARBOXYALKYL)ANILINE DERIVATIVE SUMITOMO CHEMICAL CO., LTD. (JP) 1983-09-06 US disclosed
US-4141902-A SEDATIVES, TRANQUILIZERS, MUSCLE RELAXANTS THE UPJOHN COMPANY (US) 1979-02-27 US disclosed